Fluidigm creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents and software that are used by researchers and clinical labs worldwide. Co. markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Preparation, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. Co.'s product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics. We show 50 historical shares outstanding datapoints in our coverage of FLDM's shares outstanding history.
Understanding the changing numbers of FLDM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like FLDM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching FLDM by allowing them to research FLDM shares outstanding history
as well as any other stock in our coverage universe. |
Free FLDM Email Alerts:
Video: Shares Outstanding Importance
